Historic volatility and deep uncertain ties about where the economy is headed have derailed public offerings that were otherwise likely to happen his year. Don’t expect the pace to pick up much -- at least not for a few months, according to a co-chair of Goodwin’s Capital Markets practice. Read the article in The Street here.
Related Content
- AlertApril 29, 2026
Nasdaq Adopts Enhanced SPAC IPO Listing Standards Under Both Global Market and Capital Market Tiers
- NewslettersApril 10, 2026 – April 24, 2026
SEC Staff Shortens Minimum Tender Offer Period for Certain All-Cash Offerings to 10 Business Days
- AlertApril 20, 2026
Revisiting Regulation S-K: Key Themes of Public Comments
- NewslettersApril 3, 2026 – April 16, 2026
OCC and FDIC Issue Final Rule Prohibiting Use of Reputation Risk in Supervisory Frameworks
- NewslettersMarch 29, 2026 – April 9, 2026
SEC Announces Enforcement Results for 2025
- NewslettersMarch 19, 2026 – April 2, 2026
OCC Rescinds Recovery Planning Standards and Guidelines
- NewslettersMarch 13, 2026 – March 27, 2026
SEC’s Compliance and Disclosure Interpretations Now Known as Corporation Finance Interpretations (CFIs)
- NewslettersMarch 5, 2026 – March 19, 2026
Kansas City Fed Approves Limited Purpose Account for Kraken Financial
- Speaking EngagementsApril 21, 2026
Global Capital Markets & the U.S. Securities Laws 2026
- Press ReleaseMarch 30, 2026
The Banks Jefferies, Leerink Partners, Evercore ISI, and Oddo BHF SCA Were Advised by Goodwin in Connection With the €48 Million Private Placement Carried Out by Medincell SA
- In the PressMarch 30, 2026
Investors Are Suing over Proxy Proposals — Here’s What to Know (FT Agenda)
- Awards and Rankings26 March 2026
Legal 500 EMEA 2026 Recognizes Goodwin for Excellence in France, Germany, and Luxembourg
- Press ReleaseMarch 16, 2026
The Chemours Company Completes Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
- Press ReleaseMarch 12, 2026
Goodwin Guides CRISPR Therapeutics on Pricing $550 Million Upsized Convertible Senior Notes Offering
- Press ReleaseMarch 2, 2026
Goodwin Advises on Bitdeer’s Upsized $375 Million Convertible Senior Notes Offering With Capped Call and Registered Direct Offering
- Awards and RankingsFebruary 13, 2026
Goodwin Achieves Record Number of Rankings in Chambers Global 2026